Literature DB >> 24477629

Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems.

Sergejs Isajevs1, Inta Liepniece-Karele, Dainius Janciauskas, Georgijs Moisejevs, Viesturs Putnins, Konrads Funka, Ilze Kikuste, Aigars Vanags, Ivars Tolmanis, Marcis Leja.   

Abstract

Atrophic gastritis remains a difficult histopathological diagnosis with low interobserver agreement. The aim of our study was to compare gastritis staging and interobserver agreement between general and expert gastrointestinal (GI) pathologists using Operative Link for Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia (OLGIM). We enrolled 835 patients undergoing upper endoscopy in the study. Two general and two expert gastrointestinal pathologists graded biopsy specimens according to the Sydney classification, and the stage of gastritis was assessed by OLGA and OLGIM system. Using OLGA, 280 (33.4 %) patients had gastritis (stage I-IV), whereas with OLGIM this was 167 (19.9 %). OLGA stage III- IV gastritis was observed in 25 patients, whereas by OLGIM stage III-IV was found in 23 patients. Interobserver agreement between expert GI pathologists for atrophy in the antrum, incisura angularis, and corpus was moderate (kappa = 0.53, 0.57 and 0.41, respectively, p < 0.0001), but almost perfect for intestinal metaplasia (kappa = 0.82, 0.80 and 0.81, respectively, p < 0.0001). However, interobserver agreement between general pathologists was poor for atrophy, but moderate for intestinal metaplasia. OLGIM staging provided the highest interobserver agreement, but a substantial proportion of potentially high-risk individuals would be missed if only OLGIM staging is applied. Therefore, we recommend to use a combination of OLGA and OLGIM for staging of chronic gastritis.

Entities:  

Mesh:

Year:  2014        PMID: 24477629     DOI: 10.1007/s00428-014-1544-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  24 in total

1.  The phenotype of gastric mucosa coexisting with Barrett's oesophagus.

Authors:  M Rugge; V Russo; G Busatto; R M Genta; F Di Mario; F Farinati; D Y Graham
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

2.  Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.

Authors:  Massimo Rugge; Matteo Fassan; Marco Pizzi; Fabio Farinati; Giacomo Carlo Sturniolo; Mario Plebani; David Y Graham
Journal:  World J Gastroenterol       Date:  2011-11-07       Impact factor: 5.742

3.  Staging gastritis: an international proposal.

Authors:  Massimo Rugge; Robert M Genta
Journal:  Gastroenterology       Date:  2005-11       Impact factor: 22.682

4.  Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis.

Authors:  X Y Chen; R W van der Hulst; M J Bruno; A van der Ende; S D Xiao; G N Tytgat; F J Ten Kate
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

Review 5.  How to assess the severity of atrophic gastritis.

Authors:  Yan-Cheng Dai; Zhi-Peng Tang; Ya-Li Zhang
Journal:  World J Gastroenterol       Date:  2011-04-07       Impact factor: 5.742

6.  The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis.

Authors:  Lisette G Capelle; Annemarie C de Vries; Jelle Haringsma; Frank Ter Borg; Richard A de Vries; Marco J Bruno; Herman van Dekken; Jos Meijer; Nicole C T van Grieken; Ernst J Kuipers
Journal:  Gastrointest Endosc       Date:  2010-04-09       Impact factor: 9.427

7.  Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study.

Authors:  M Rugge; M de Boni; G Pennelli; M de Bona; L Giacomelli; M Fassan; D Basso; M Plebani; D Y Graham
Journal:  Aliment Pharmacol Ther       Date:  2010-02-23       Impact factor: 8.171

8.  The Vienna classification of gastrointestinal epithelial neoplasia.

Authors:  R J Schlemper; R H Riddell; Y Kato; F Borchard; H S Cooper; S M Dawsey; M F Dixon; C M Fenoglio-Preiser; J F Fléjou; K Geboes; T Hattori; T Hirota; M Itabashi; M Iwafuchi; A Iwashita; Y I Kim; T Kirchner; M Klimpfinger; M Koike; G Y Lauwers; K J Lewin; G Oberhuber; F Offner; A B Price; C A Rubio; M Shimizu; T Shimoda; P Sipponen; E Solcia; M Stolte; H Watanabe; H Yamabe
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

9.  Interobserver variation in assessment of gastric premalignant lesions: higher agreement for intestinal metaplasia than for atrophy.

Authors:  Marcis Leja; Konrads Funka; Dainius Janciauskas; Viesturs Putnins; Agnese Ruskule; Ilze Kikuste; Una Kojalo; Ivars Tolmanis; Janis Misins; Karlis Purmalis; Sergey Pimanov; Jelena Makarenko; Limas Kupcinskas; Uldis Vikmanis
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-06       Impact factor: 2.566

10.  Serological assessment of gastric mucosal atrophy in gastric cancer.

Authors:  Jan Bornschein; Michael Selgrad; Thomas Wex; Doerthe Kuester; Peter Malfertheiner
Journal:  BMC Gastroenterol       Date:  2012-01-31       Impact factor: 3.067

View more
  18 in total

1.  High Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the USA.

Authors:  Christie E Choi; Amnon Sonnenberg; Kevin Turner; Robert M Genta
Journal:  Dig Dis Sci       Date:  2015-02-28       Impact factor: 3.199

Review 2.  Recent Guidelines on the Management of Patients with Gastric Atrophy: Common Points and Controversies.

Authors:  Tamara Matysiak-Budnik; Maria Constanza Camargo; Maria Blanca Piazuelo; Marcis Leja
Journal:  Dig Dis Sci       Date:  2020-07       Impact factor: 3.199

3.  Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.

Authors:  Ying Zhou; Hai-Yan Li; Jing-Jing Zhang; Xiao-Yu Chen; Zhi-Zheng Ge; Xiao-Bo Li
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

4.  The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.

Authors:  Hu Yue; Liu Shan; Lv Bin
Journal:  Gastric Cancer       Date:  2018-02-19       Impact factor: 7.370

Review 5.  [Precursors of gastric cancer : Dysplasia and adenoma].

Authors:  C Langner
Journal:  Pathologe       Date:  2017-03       Impact factor: 1.011

6.  Prevalence of Gastric Preneoplastic Lesions in First-Degree Relatives of Patients with Gastric Cancer: a Cross-Sectional Study.

Authors:  Sergio Sotelo; Carlos Manterola; Tamara Otzen; Erik Morales; Iván Castillo
Journal:  J Gastrointest Cancer       Date:  2022-04-30

Review 7.  Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.

Authors:  Kevin Sze-Hang Liu; Irene Oi-Ling Wong; Wai K Leung
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

8.  High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.

Authors:  Sergejs Isajevs; Selga Savcenko; Inta Liepniece-Karele; Maria Blanca Piazuelo; Ilze Kikuste; Ivars Tolmanis; Aigars Vanags; Indra Gulbe; Linda Mezmale; Darhan Samentaev; Altynbek Tazedinov; Ramis Samsutdinov; Tatjana Belihina; Nurbek Igissinov; Marcis Leja
Journal:  Virchows Arch       Date:  2021-05-14       Impact factor: 4.064

9.  Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres Across Europe.

Authors:  Jan Bornschein; Terry Tran-Nguyen; Gloria Fernandez-Esparrach; Stephen Ash; Francesc Balaguer; Elizabeth L Bird-Lieberman; Henry Córdova; Zane Dzerve; Matteo Fassan; Marcis Leja; Ivan Lyutakov; Tim Middelburg; Leticia Moreira; Radislav Nakov; Stella A V Nieuwenburg; Anthony O'Connor; Stefano Realdon; Heiko De Schepper; Annemieke Smet; M C W Spaander; Ivars Tolmanis; Tadas Urbonas; Jochen Weigt; Georgina L Hold; Alexander Link; Juozas Kupcinskas
Journal:  Dig Dis       Date:  2020-10-01       Impact factor: 2.404

10.  Interobserver and intraobserver agreement for gastric mucosa atrophy.

Authors:  Tomohiro Miwata; Duc Trong Quach; Toru Hiyama; Rika Aoki; Huy Minh Le; Phuong Luu Ngoc Tran; Masanori Ito; Shinji Tanaka; Koji Arihiro; Naomi Uemura; Kazuaki Chayama
Journal:  BMC Gastroenterol       Date:  2015-08-04       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.